Bausch Health Companies Inc
BHC
Company Profile
Business description
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Contact
2150 Saint Elzear Boulvard West
LavalQCH7L 4A8
CANT: +1 514 744-6792
E: arthur.shannon@bauschhealth.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
20,700
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 7,910.50 | 348.80 | 4.61% |
CAC 40 | 6,896.91 | 203.51 | -2.87% |
DAX 40 | 19,670.88 | 609.38 | -3.00% |
Dow JONES (US) | 40,608.45 | 62.52 | 0.15% |
FTSE 100 | 7,705.87 | 204.66 | -2.59% |
HKSE | 20,628.86 | 364.37 | 1.80% |
NASDAQ | 17,124.97 | 574.37 | 3.47% |
Nikkei 225 | 34,326.90 | 2,612.87 | 8.24% |
NZX 50 Index | 12,183.27 | 376.72 | 3.19% |
S&P 500 | 5,456.90 | 474.13 | 9.52% |
S&P/ASX 200 | 7,708.90 | 333.90 | 4.53% |
SSE Composite Index | 3,216.41 | 29.60 | 0.93% |